药监局-话题@MedSci

#药监局#

232篇内容 | 1786人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1301755, encodeId=5cbb1301e55bb, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：常用消炎镇痛药说明书修订，9类人禁用！, objectType=article, longId=730744, objectId=a21de3074431, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a21de3074431, replyNumber=0, likeNumber=42, createdTime=2022-06-30, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a21de3074431, moduleTitle=国家药监局：常用消炎镇痛药说明书修订，9类人禁用！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a21de3074431)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301754, encodeId=0d891301e5458, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局拟规定：第三方平台不能直接网络销售药品, objectType=article, longId=730564, objectId=4583e3056449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4583e3056449, replyNumber=0, likeNumber=42, createdTime=2022-06-28, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4583e3056449, moduleTitle=国家药监局拟规定：第三方平台不能直接网络销售药品, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4583e3056449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301753, encodeId=06101301e53f1, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：严把医疗器械质量安全关, objectType=article, longId=728139, objectId=cc24e2813964, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc24e2813964, replyNumber=0, likeNumber=47, createdTime=2022-05-31, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc24e2813964, moduleTitle=国家药监局：严把医疗器械质量安全关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc24e2813964)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301752, encodeId=27d31301e52e2, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=冰洲石生物自主研发的创新雌激素受体嵌合降解剂AC0682临床申请获国家药监局批准, objectType=article, longId=723698, objectId=a233e2369829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a233e2369829, replyNumber=0, likeNumber=36, createdTime=2022-04-08, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a233e2369829, moduleTitle=冰洲石生物自主研发的创新雌激素受体嵌合降解剂AC0682临床申请获国家药监局批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a233e2369829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301751, encodeId=5cb61301e51c0, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局已批准20个新冠病毒抗原检测试剂, objectType=article, longId=302052, objectId=5d7730205259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d7730205259, replyNumber=0, likeNumber=40, createdTime=2022-04-01, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d7730205259, moduleTitle=国家药监局已批准20个新冠病毒抗原检测试剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d7730205259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301750, encodeId=19111301e50d7, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局公布《允许发布处方药广告的医学药学专业刊物名单》, objectType=article, longId=300470, objectId=0c8e3004e05b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c8e3004e05b, replyNumber=0, likeNumber=43, createdTime=2022-03-12, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c8e3004e05b, moduleTitle=国家药监局公布《允许发布处方药广告的医学药学专业刊物名单》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c8e3004e05b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301749, encodeId=18d61301e49b4, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局提醒：小金盾不是儿童化妆品质量认证标志, objectType=article, longId=300285, objectId=93d2300285b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93d2300285b7, replyNumber=0, likeNumber=40, createdTime=2022-03-10, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93d2300285b7, moduleTitle=国家药监局提醒：小金盾不是儿童化妆品质量认证标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93d2300285b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301748, encodeId=230f1301e486c, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局CDE相关指导原则, objectType=article, longId=219295, objectId=1c8921929595, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c8921929595, replyNumber=0, likeNumber=26, createdTime=2021-10-28, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c8921929595, moduleTitle=国家药监局CDE相关指导原则, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c8921929595)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301747, encodeId=7c811301e4757, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局批准恒瑞医药普瑞巴林缓释片用于治疗成人慢性神经性疼痛, objectType=article, longId=217887, objectId=252921e88739, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=252921e88739, replyNumber=0, likeNumber=53, createdTime=2021-10-01, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=252921e88739, moduleTitle=国家药监局批准恒瑞医药普瑞巴林缓释片用于治疗成人慢性神经性疼痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=252921e88739)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301746, encodeId=bd7c1301e4655, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理, objectType=article, longId=215388, objectId=bc0f21538845, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc0f21538845, replyNumber=0, likeNumber=46, createdTime=2021-08-08, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc0f21538845, moduleTitle=PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc0f21538845)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301745, encodeId=3ecf1301e4541, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：关于贯彻实施《医疗器械监督管理条例》有关事项的公告, objectType=article, longId=212146, objectId=2e4321214674, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e4321214674, replyNumber=0, likeNumber=39, createdTime=2021-06-03, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e4321214674, moduleTitle=国家药监局：关于贯彻实施《医疗器械监督管理条例》有关事项的公告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e4321214674)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301744, encodeId=40fe1301e44c0, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：化妆品禁用原料目录更新！, objectType=article, longId=212096, objectId=83b4212096b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83b4212096b0, replyNumber=0, likeNumber=37, createdTime=2021-06-02, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83b4212096b0, moduleTitle=国家药监局：化妆品禁用原料目录更新！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83b4212096b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301743, encodeId=83d41301e431a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局发文：77项医疗器械行业全新标准来了！, objectType=article, longId=211912, objectId=b775211912e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b775211912e9, replyNumber=0, likeNumber=27, createdTime=2021-05-29, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b775211912e9, moduleTitle=国家药监局发文：77项医疗器械行业全新标准来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b775211912e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301742, encodeId=90241301e424a, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=无创新疗法治疗震颤取得里程碑进展，“磁波刀”神外解决方案获批药监局批准在华正式投入临床, objectType=article, longId=211775, objectId=e164211e7541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e164211e7541, replyNumber=0, likeNumber=47, createdTime=2021-05-26, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e164211e7541, moduleTitle=无创新疗法治疗震颤取得里程碑进展，“磁波刀”神外解决方案获批药监局批准在华正式投入临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e164211e7541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301741, encodeId=45311301e41f9, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则（试行）》, objectType=article, longId=210032, objectId=a86f2100326d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a86f2100326d, replyNumber=0, likeNumber=41, createdTime=2021-04-17, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a86f2100326d, moduleTitle=国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则（试行）》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a86f2100326d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301740, encodeId=c43c1301e404c, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：中国是世界上**出台专门的疫苗管理法国家, objectType=article, longId=209423, objectId=317520942340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=317520942340, replyNumber=0, likeNumber=37, createdTime=2021-04-05, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=317520942340, moduleTitle=国家药监局：中国是世界上**出台专门的疫苗管理法国家, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=317520942340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301739, encodeId=533b1301e3981, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：92个医疗器械产品获批上市, objectType=article, longId=208908, objectId=040020890803, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=040020890803, replyNumber=0, likeNumber=41, createdTime=2021-03-25, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=040020890803, moduleTitle=国家药监局：92个医疗器械产品获批上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=040020890803)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301738, encodeId=4ef11301e38af, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局附条件批准两家公司新冠疫苗注册申请, objectType=article, longId=208002, objectId=33a62080024d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33a62080024d, replyNumber=0, likeNumber=32, createdTime=2021-03-08, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33a62080024d, moduleTitle=国家药监局附条件批准两家公司新冠疫苗注册申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33a62080024d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301737, encodeId=c92d1301e37ea, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局附条件批准国药中生武汉公司新型冠状病毒灭活疫苗（Vero细胞）注册申请, objectType=article, longId=207636, objectId=ec0a20e636ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec0a20e636ea, replyNumber=0, likeNumber=41, createdTime=2021-02-28, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec0a20e636ea, moduleTitle=国家药监局附条件批准国药中生武汉公司新型冠状病毒灭活疫苗（Vero细胞）注册申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec0a20e636ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1301736, encodeId=84281301e3685, content=<a href='/topic/show?id=2ba78e935dc' target=_blank style='color:#2F92EE;'>#药监局#</a>, objectTitle=国家药监局：全力推进疫苗药品应急审评审批, objectType=article, longId=206882, objectId=9020206882c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9020206882c4, replyNumber=0, likeNumber=29, createdTime=2021-02-08, rootId=0, userName=xuyu, userId=8f5b299, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9020206882c4, moduleTitle=国家药监局：全力推进疫苗药品应急审评审批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9020206882c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药监局

2020-05-29

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：常用消炎镇痛药说明书修订，9类人禁用！

2022-06-30

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局拟规定：第三方平台不能直接网络销售药品

2022-06-28

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：严把医疗器械质量安全关

2022-05-31

xuyu (审核中...)

前往app查看评论内容

#药监局#

冰洲石生物自主研发的创新雌激素受体嵌合降解剂AC0682临床申请获国家药监局批准

2022-04-08

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局已批准20个新冠病毒抗原检测试剂

2022-04-01

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局公布《允许发布处方药广告的医学药学专业刊物名单》

2022-03-12

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局提醒：小金盾不是儿童化妆品质量认证标志

2022-03-10

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局CDE相关指导原则

2021-10-28

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局批准恒瑞医药普瑞巴林缓释片用于治疗成人慢性神经性疼痛

2021-10-01

xuyu (审核中...)

前往app查看评论内容

#药监局#

PD-1/L1竞争再加剧，中国生物制药与康方生物研发的治疗鼻咽癌新药上市申请获国家药监局受理

2021-08-08

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：关于贯彻实施《医疗器械监督管理条例》有关事项的公告

2021-06-03

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：化妆品禁用原料目录更新！

2021-06-02

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局发文：77项医疗器械行业全新标准来了！

2021-05-29

xuyu (审核中...)

前往app查看评论内容

#药监局#

无创新疗法治疗震颤取得里程碑进展，“磁波刀”神外解决方案获批药监局批准在华正式投入临床

2021-05-26

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局药审中心关于发布《用于产生真实世界证据的真实世界数据指导原则（试行）》

2021-04-17

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：中国是世界上**出台专门的疫苗管理法国家

2021-04-05

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：92个医疗器械产品获批上市

2021-03-25

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局附条件批准两家公司新冠疫苗注册申请

2021-03-08

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局附条件批准国药中生武汉公司新型冠状病毒灭活疫苗（Vero细胞）注册申请

2021-02-28

xuyu (审核中...)

前往app查看评论内容

#药监局#

国家药监局：全力推进疫苗药品应急审评审批

2021-02-08

科室
- - 订阅+
  - 更多科室
工具
服务